Michelle Hoffman
This is the bio for Michelle Hoffman, editor-in-chief of Pharmaceutical Technology magazine.
Michelle Hoffman
Editor-in-chief
732.346.3014, mhoffman@advanstar.com
Michelle joined Pharmaceutical Technology in 2007. She previously served as editor-in-chief of Drug Discovery & Development, G&P, and BioPerform. She has served as the senior science editor for Harvard Medical School followed by almost a decade as the associate editor (life sciences) for American Scientist magazine. In addition, she was formerly a member of the news staff at Science magazine and an editor at Cell. During her business career, she has been a member of the launch teams of two biotech startups, Quantum Genomics (functional genomics) and Karyogen (drug discovery). Michelle also analyzed new ventures at BD Technologies (part of Becton Dickinson) as a member of the business development group. She was trained in molecular biology at Brown and Harvard and holds an MBA from the University of North Carolina at Chapel Hill, where she specialized in corporate finance and entrepreneurship.
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Prokaryotics Licenses Gram-Negative Antibiotic Potentiator from Northern Antibiotics
June 26th 2025Prokaryotics will gain worldwide rights to develop, manufacture, and commercialize NAB741, a non-bioactive polymyxin designed to increase permeability of the outer membrane of Gram-negative bacteria.
